Knowledge mapping of immunotherapy for breast cancer: A bibliometric analysis from 2013 to 2022
Breast cancer is the leading cause of cancer-related death among women globally. Immunotherapy has emerged as a major milestone in contemporary oncology. This study aims to conduct a bibliometric analysis in the field of immunotherapy for breast cancer, providing a comprehensive overview of the curr...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2335728 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849717329101848576 |
|---|---|
| author | Fanli Qu Guanwen Wang Ping Wen Xiaoyu Liu Xiaohua Zeng |
| author_facet | Fanli Qu Guanwen Wang Ping Wen Xiaoyu Liu Xiaohua Zeng |
| author_sort | Fanli Qu |
| collection | DOAJ |
| description | Breast cancer is the leading cause of cancer-related death among women globally. Immunotherapy has emerged as a major milestone in contemporary oncology. This study aims to conduct a bibliometric analysis in the field of immunotherapy for breast cancer, providing a comprehensive overview of the current research status, identifying trends and hotspots in research topics. We searched and retrieved data from the Web of Science Core Collection, and performed a bibliometric analysis of publications on immunotherapy for breast cancer from 2013 to 2022. Current status and hotspots were evaluated by co-occurrence analysis using VOSviewer. Evolution and bursts of knowledge base were assessed by co-citation analysis using CiteSpace. Thematic evolution by bibliometrix package was used to discover keywords trends. The attribution and collaboration of countries/regions, institutions and authors were also explored. A total of 7,975 publications were included. In co-occurrence analysis of keywords, 6 major clusters were revealed: tumor microenvironment, prognosis biomarker, immune checkpoints, novel drug delivery methods, immune cells and therapeutic approaches. The top three most frequently mentioned keywords were tumor microenvironment, triple-negative breast cancer, and programmed cell death ligand 1. The most productive country, institution and author were the USA (2926 publications), the University of Texas MD Anderson Cancer Center (219 publications), and Sherene Loi (28 publications), respectively. There has been a rapid growth in studies on immunotherapy for breast cancer worldwide. This research area has gained increasing attention from different countries and institutions. With the rising incidence of breast cancer, immunotherapy represents a research field of significant clinical value and potential. |
| format | Article |
| id | doaj-art-141f1e0d4fb441eea7aafdcc037817d3 |
| institution | DOAJ |
| issn | 2164-5515 2164-554X |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj-art-141f1e0d4fb441eea7aafdcc037817d32025-08-20T03:12:41ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2024-12-0120110.1080/21645515.2024.2335728Knowledge mapping of immunotherapy for breast cancer: A bibliometric analysis from 2013 to 2022Fanli Qu0Guanwen Wang1Ping Wen2Xiaoyu Liu3Xiaohua Zeng4Department of Breast Cancer Center, Chongqing University Cancer Hospital, Chongqing, ChinaDepartment of Breast Cancer Center, Chongqing University Cancer Hospital, Chongqing, ChinaSchool of Medicine, Chongqing University, Chongqing, ChinaDepartment of Breast Cancer Center, Chongqing University Cancer Hospital, Chongqing, ChinaDepartment of Breast Cancer Center, Chongqing University Cancer Hospital, Chongqing, ChinaBreast cancer is the leading cause of cancer-related death among women globally. Immunotherapy has emerged as a major milestone in contemporary oncology. This study aims to conduct a bibliometric analysis in the field of immunotherapy for breast cancer, providing a comprehensive overview of the current research status, identifying trends and hotspots in research topics. We searched and retrieved data from the Web of Science Core Collection, and performed a bibliometric analysis of publications on immunotherapy for breast cancer from 2013 to 2022. Current status and hotspots were evaluated by co-occurrence analysis using VOSviewer. Evolution and bursts of knowledge base were assessed by co-citation analysis using CiteSpace. Thematic evolution by bibliometrix package was used to discover keywords trends. The attribution and collaboration of countries/regions, institutions and authors were also explored. A total of 7,975 publications were included. In co-occurrence analysis of keywords, 6 major clusters were revealed: tumor microenvironment, prognosis biomarker, immune checkpoints, novel drug delivery methods, immune cells and therapeutic approaches. The top three most frequently mentioned keywords were tumor microenvironment, triple-negative breast cancer, and programmed cell death ligand 1. The most productive country, institution and author were the USA (2926 publications), the University of Texas MD Anderson Cancer Center (219 publications), and Sherene Loi (28 publications), respectively. There has been a rapid growth in studies on immunotherapy for breast cancer worldwide. This research area has gained increasing attention from different countries and institutions. With the rising incidence of breast cancer, immunotherapy represents a research field of significant clinical value and potential.https://www.tandfonline.com/doi/10.1080/21645515.2024.2335728Breast cancerimmunotherapybibliometricimmune checkpointtumor microenvironment |
| spellingShingle | Fanli Qu Guanwen Wang Ping Wen Xiaoyu Liu Xiaohua Zeng Knowledge mapping of immunotherapy for breast cancer: A bibliometric analysis from 2013 to 2022 Human Vaccines & Immunotherapeutics Breast cancer immunotherapy bibliometric immune checkpoint tumor microenvironment |
| title | Knowledge mapping of immunotherapy for breast cancer: A bibliometric analysis from 2013 to 2022 |
| title_full | Knowledge mapping of immunotherapy for breast cancer: A bibliometric analysis from 2013 to 2022 |
| title_fullStr | Knowledge mapping of immunotherapy for breast cancer: A bibliometric analysis from 2013 to 2022 |
| title_full_unstemmed | Knowledge mapping of immunotherapy for breast cancer: A bibliometric analysis from 2013 to 2022 |
| title_short | Knowledge mapping of immunotherapy for breast cancer: A bibliometric analysis from 2013 to 2022 |
| title_sort | knowledge mapping of immunotherapy for breast cancer a bibliometric analysis from 2013 to 2022 |
| topic | Breast cancer immunotherapy bibliometric immune checkpoint tumor microenvironment |
| url | https://www.tandfonline.com/doi/10.1080/21645515.2024.2335728 |
| work_keys_str_mv | AT fanliqu knowledgemappingofimmunotherapyforbreastcancerabibliometricanalysisfrom2013to2022 AT guanwenwang knowledgemappingofimmunotherapyforbreastcancerabibliometricanalysisfrom2013to2022 AT pingwen knowledgemappingofimmunotherapyforbreastcancerabibliometricanalysisfrom2013to2022 AT xiaoyuliu knowledgemappingofimmunotherapyforbreastcancerabibliometricanalysisfrom2013to2022 AT xiaohuazeng knowledgemappingofimmunotherapyforbreastcancerabibliometricanalysisfrom2013to2022 |